Variable | Taurine group (n = 60) | Placebo group (n = 60) | P-value |
---|---|---|---|
Age (years)a | 52.13 ± 8.1 | 53.08.1 ± 8.8 | 0.686d |
Gender [17]b | 48 (80) | 49 (81) | 0.500 |
Weighta (kg) at study baseline | 78.88 ± 8.3 | 79.2 ± 9.1 | 0.835d |
Weight (kg) after intervention | 75.44 ± 9.4 | 77.10 ± 8.2 | 0.315 |
BMI at study baseline | 27.94 ± 6.9 | 28.01 ± 7.1 | 0.835d |
BMI after intervention | 26.80 ± 9.4 | 27.25 ± 8.2 | 0.225 |
Diabetes duration (years) | 5.1 ± 1.3 | 4.9 ± 1.2 | 0.407 |
Active Smokingb | 5 (8) | 4 (6) | 0.650c |
Physical activity (METs) | 773.7 ± 198.3 | 760.6 ± 201.21 | 0.830 |
Metformin use, n (%) | 48 (80) | 47 (78) | 0.499 |
Glibenclamide use, n (%) | 33 (53) | 31 (49) | 0.580 |